Nick Wojton - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Nick Wojton's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Nick Wojton
Verified
Editorial Producer, SportsNet New York (SNY)
United States
Beats
Biography
USAT
Sports , Beer, Lists , Pets, Food, Surveys
Content
By Nick Wojton Verified| USA Today Verified ESPN NFL insider Field Yates has made a bold prediction for the Buffalo Bills ahead of the 2025 NFL draft. Yates named teams he believes could be moving around the upcoming event in April in Round 1. In the category of trading up, only three clubs were named. The Bills were one of them. While a big projection to make, it's not all that surprising. Over the years, Buffalo general manager Brandon Beane has not been afraid to move both up and down the board.
By Nick Wojton Verified| USA Today Verified New York Jets general manager Darren Mougey used Justin Fields to make both his first big decision and proclamation in his new job. The GM offered and convinced the 26-year-old quarterback to sign on the dotted line in New York during free agency. From there, Mougey then canceled out any questions. He proclaimed Fields as his starter in 2025. While Fields himself said he tried not to let him being benched last season by the Pittsburgh Steelers influence his decision...
By Nick Wojton Verified| USA Today Verified ESPN NFL insider Field Yates has made a bold prediction for the Buffalo Bills ahead of the 2025 NFL draft. Yates named teams he believes could be moving around the upcoming event in April in Round 1. In the category of trading up, only three clubs were named. The Bills were one of them. While a big projection to make, it's not all that surprising. Over the years, Buffalo general manager Brandon Beane has not been afraid to move both up and down the board.
Company Info
SportsNet New York (SNY)
Sanofi FR, represented by the ticker symbol SNY, is a prominent French multinational pharmaceutical and healthcare company. It is recognized for its expertise in drug development and vaccine research. Sanofi is dedicated to addressing complex health challenges globally through a research-driven approach and a diverse range of therapeutic solutions. The company operates in several key healthcare segments, including pharmaceuticals, vaccines, consumer healthcare, and specialty therapeutics. Sanofi develops and commercializes therapeutic drugs for conditions such as cancer, diabetes, and immunological disorders. It also produces vaccines to prevent infectious diseases and offers over-the-counter health products to enhance everyday well-being. With a strong presence in both mature and emerging markets, Sanofi serves a wide customer base, including healthcare providers, hospitals, and governments, ensuring the delivery of sustainable medical solutions worldwide.
'+1 212-485-4800
Founded: 2005